TrialHypertension research : official journal of the Japanese Society of Hypertension2015

Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction.

Sadayoshi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.